Position history for GILDER GAGNON HOWE & CO LLC's holdings in ARCUTIS BIOTHERAPEUTICS INC
GILDER GAGNON HOWE & CO LLC holds 4.3M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $101.4M as of 2026-Q1. The position was decreased (-3.4% shares). ARQT represents 1.2% of GILDER GAGNON HOWE & CO LLC's portfolio.
Current Value
$101.4M
Current Shares
4.3M
Total Value Change
+$67.8M
Total Shares Change
+687,478
Other major holders of ARQT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 4.3M |
-3.4% |
| $101.4M |
| 1.2% |
| $23.60 |
0 |
| 2025-Q4 | Increased | 4.5M | +0.6% | $129.3M | 1.4% | $28.08 | 48 |
| 2025-Q3 | Increased | 4.4M | +6.6% | $83.5M | 0.9% | $18.62 | 45 |
| 2025-Q2 | Increased | 4.2M | +1.5% | $58.3M | 0.6% | $13.74 | 42 |
| 2025-Q1 | Increased | 4.1M | +5.0% | $64.1M | 0.8% | $15.73 | 44 |
| 2024-Q4 | Increased | 3.9M | +9.8% | $54.4M | 0.6% | $14.20 | 46 |
| 2024-Q3 | Decreased | 3.6M | -1.7% | $33.1M | 0.4% | $9.36 | 0 |
| 2024-Q2 | Decreased | 3.6M | -14.6% | $33.6M | 0.4% | $9.30 | 0 |